Overview
The goal of this clinical trial is to learn if an intensive program can treat post-traumatic stress disorder (PTSD) in adults getting treatment for the first time, and whether it has lower societal costs. The main questions it aims to answer are:
- Does an intensive program reduce PTSD symptoms?
- How expensive is it on a societal level? Researchers will compare the intensive program to the standard weekly treatment to see if the intensive program works to treat PTSD.
Participants will:
- Get 5 days of intensive treatment in two weeks (with two preparatory and closing sessions), or weekly sessions
- Get questionnaires and interviews 5 times in 9 months
Eligibility
Inclusion Criteria:
- 18 years or older
- PTSD diagnosis according to DSM-5 (CAPS-5);
- PTSD diagnosis stemming from 2 or more potentially traumatic events (PTEs)
- seeking first-time treatment for PTSD (or less than 8 sessions);
- employed (working or on sick leave for less than two years)
Exclusion Criteria:
- Current psychotic disorder, severe alcohol or substance use disorder, high suicidal intent (MINI-S for DSM-5) and a concrete suicide plan, or severe aggressive behavior that poses danger for others
- insufficient command of the Dutch language to be able to complete the assessments. This will be determined through clinical judgment at intake.